[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved generic versions of Gilenya, a multiple sclerosis (MS) medication. Gilenya (fingolimod) is used to treat adults with relapsing
[ad_1] (RxWiki News) A recent study found a possible link between organic solvents and increased multiple sclerosis (MS) risk in people with genes that make them more susceptible to developing
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has expanded the approval of a multiple sclerosis (MS) medication to treat the condition in children. This medication is found
[ad_1] (RxWiki News) A multiple sclerosis treatment is being withdrawn from the market, according to the US Food and Drug Administration (FDA). Biogen and Abbvie announced they are voluntarily withdrawing
[ad_1] Mothers who breastfeed their children longer may be less likely to develop multiple sclerosis (MS), according to a new study. [ad_2] Source link
[ad_1] (RxWiki News) A newly approved multiple sclerosis (MS) medication is the first ever approved by the US Food and Drug Administration (FDA) to treat a particular type of MS. The
